Loading…

Epilepsy in Rett syndrome—The experience of a National Rett Center

Summary Purpose:  Rett syndrome (RTT), an X‐linked, dominant neurodevelopmental disorder caused by mutations in the methyl‐CpG‐binding protein 2 (MECP2) gene, presents with acquired microcephaly, autistic regression, hand usage loss, and stereotypies. Epilepsy is frequent and has been reported to co...

Full description

Saved in:
Bibliographic Details
Published in:Epilepsia (Copenhagen) 2010-07, Vol.51 (7), p.1252-1258
Main Authors: Nissenkorn, Andreea, Gak, Eva, Vecsler, Manuela, Reznik, Haia, Menascu, Shay, Ben Zeev, Bruria
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Purpose:  Rett syndrome (RTT), an X‐linked, dominant neurodevelopmental disorder caused by mutations in the methyl‐CpG‐binding protein 2 (MECP2) gene, presents with acquired microcephaly, autistic regression, hand usage loss, and stereotypies. Epilepsy is frequent and has been reported to correlate with mutation type, general disease severity, and BDNF polymorphism. Our purpose was a comprehensive description of epilepsy features and course in RTT. Methods:  Retrospective review of charts and electroencephalography (EEG) studies in 97 patients with RTT. Results:  Seventy‐two percent of patients had epilepsy, appearing at a median age of 3 years. According to age of onset, we divided patients into three groups: 6 with early epileptic variant (0–1 year), 42 with early epilepsy (1–5 years), and 20 with late epilepsy (after 5 years). Early epileptic variant had severe seizure types in the first year of life, followed by a typical RTT picture; all were MECP2 negative. Early epilepsy and late epilepsy groups were similar with respect to Rett‐related symptoms, but seizures were better controlled in the second group (p 
ISSN:0013-9580
1528-1167
DOI:10.1111/j.1528-1167.2010.02597.x